Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: A follow-up case-control association study of tractable (druggable) genes in recurrent major depression
Author: Schosser, A.
Gaysina, D.
Cohen-Woods, S.
Domenici, E.
Perry, J.
Tozzi, F.
Korszun, A.
Gunasinghe, C.
Gray, J.
Jones, L.
Binder, E.
Holsboer, F.
Craddock, N.
Owen, M.
Craig, I.
Farmer, A.
Muglia, P.
McGuffin, P.
Citation: American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2011; 156B(6):640-650
Publisher: Wiley-Liss
Issue Date: 2011
ISSN: 1552-4841
Statement of
A. Schosser, D. Gaysina, S. Cohen-Woods, E. Domenici, J. Perry, F. Tozzi, A. Korszun, C. Gunasinghe, J. Gray, L. Jones, E.B. Binder, F. Holsboer, N. Craddock, M.J. Owen, I.W. Craig, A.E. Farmer, P. Muglia, and P. McGuffin
Abstract: The High-Throughput Disease-specific target Identification Program (HiTDIP) aimed to study case-control association samples for 18 common diseases. Here we present the results of a follow-up case-control association study of HiTDIP in major depressive disorder (MDD). The HiTDIP in MDD was conducted in a sample of 974 cases of recurrent MDD of white German origin collected at the Max-Planck Institute (MP-GSK) and 968 ethnically matched controls screened for lifetime absence of depression. Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A). Within the current study, we attempted to follow-up these findings in a sample from the UK, the Depression Case Control (DeCC) sample consisting of 1,196 cases and 842 screened controls, phenotyped using exactly the same methods as the MP-GSK sample. Performing Cochran-Mantel-Haenzel statistics to test for genotypic and/or allelic differences between the DeCC and MP-GSK samples, we found no significant differences, thus being able to combine the two samples for association testing. In the combined sample of 2,170 MDD cases and 1,810 controls, there were positive findings in the Nitric Oxide Synthase 2A (NOS2A) gene both using single SNP analysis and haplotype analysis.
Keywords: depression
candidate genes
case–control study
Rights: Copyright © 2011 Wiley-Liss, Inc.
DOI: 10.1002/ajmg.b.31204
Published version:
Appears in Collections:Aurora harvest
Psychiatry publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.